Search

everythinglearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Skin hormone levels change significantly after menopause.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

New hybrid compound found to effectively prevent hair loss.

Some herbs show promise as antiandrogenic agents.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Dutasteride is approved to help manage prostate enlargement.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

New genes and pathways are important for testosterone production and male sexual development.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.